用于瘤治疗的分子粘合剂降解剂
Yuhan Hu1, Yan Yan2, Jiehao Wang3
1Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
Frontiers in oncology
|January 6, 2025
概括
分子粘合剂是针对蛋白质降解的新前沿,在抗瘤治疗中比PROTACs具有优势. 本综述涵盖了它们的机制,临床潜力和新型小分子药物的设计策略.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 向蛋白降解 (TPD) 是抗瘤治疗研究的一个关键领域.
- 蛋白质溶解向金马 (PROTACs) 是TPD的一个重大进步.
- 口服药物HP518已获得FDA批准,用于前列腺癌治疗的新药研究 (IND) 应用.
研究的目的:
- 审查分子合剂作为治疗方式的新兴领域.
- 为了突出分子粘剂在PROTACs上的优势.
- 总结当前的研究,临床应用和分子治疗的设计策略.
主要方法:
- 关于分子合剂机制的文献综述.
- 在临床试验中分析有前途的分子剂药物.
- 探索分子治疗的各种设计策略.
主要成果:
- 分子粘合剂通过诱导蛋白降解来起作用.
- 它们比PROTACs具有潜在的优势,包括提高效率和准"无药"蛋白质.
- 这种模式代表了小分子药物开发的革命性进步.
结论:
- 分子是瘤学中一个有前途的治疗策略.
- 鉴于该领域的早期阶段,进一步的研究和开发是合理的.
- 分子具有治疗包括癌症在内的各种疾病的巨大潜力.
更多相关视频
10:10Spatiotemporally Controlled Nuclear Translocation of Guests in Living Cells Using Caged Molecular Glues as Photoactivatable Tags
Published on: January 17, 2019
10.4K
08:40TAPE: A Biodegradable Hemostatic Glue Inspired by a Ubiquitous Compound in Plants for Surgical Application
Published on: June 8, 2016
14.1K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K